Smart post, Buildit. The PR didn’t indicate anything at all of needing to move forward without their partners in China including the Chinese CDC. I agree with your theory that if there’s anything taking time it’s setting up the new entity in China. To me, the difficulty is that Generex is a US company, but that’s something they did or will quickly overcome. Although I don’t think it’s something to worry about at this time. I’m optimistic about it.
(3)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links